Introduction {#s1}
============

A relatively small number of highly conserved cellular signaling pathways are responsible for a broad array of distinct, specific biological processes in metazoan development. It is clear that these pathways must interact in a combinatorial and context-dependent manner to produce the wide and diverse range of downstream events required for development, homeostasis, and disease.

One of these fundamental signaling mechanisms is the Notch pathway, which is conserved amongst all metazoans and controls a wide range of cell fate decisions ([@bib4]; [@bib43]). Aberrant Notch signaling levels can lead to developmental defects and various pathological conditions including cancer ([@bib3]; [@bib58]; [@bib44]). In addition to the well-documented causative role of activating Notch mutations in T-cell acute lymphoblastic leukemia ([@bib15]; [@bib77]), Notch activity has been positively correlated with a number of solid cancers, including those of the breast, prostate, skin, brain, lung, colon, and pancreas ([@bib36]; [@bib58]). However, Notch can also act as a tumor suppressor in other contexts ([@bib14]). The specific mechanisms by which Notch contributes to oncogenesis remain largely opaque, although it seems clear that integration with other genes in a context-dependent fashion are key for mediating the action of Notch and its involvement in pro-oncogenic events as proliferation and metastasis.

Ligand binding to the Notch cell surface receptor results in a series of cleavages that release the active C-terminus, which subsequently translocates to the nucleus and modulates the transcription of target genes ([@bib3]; [@bib26]). Given that Notch is highly pleiotropic, it is clear that the developmentally crucial and highly specific downstream responses to Notch signal activation depend on its cellular context and the integration of the signal with other signaling pathways ([@bib28]; [@bib10]). Indeed, a number of genetic screens in our lab and others have revealed a staggering number of genes that interact with Notch to modulate downstream phenotypes; given that the results from these studies, which encompass various biological processes, have surprisingly little overlap, it seems likely that the full gamut of genes that can genetically interact with and influence Notch has not yet been identified ([@bib33]; [@bib27]; [@bib67]; [@bib65]; [@bib22]).

We previously reported a synergistic interaction between activated Notch and the transcription factor Mef2, and showed that it activates the JNK signaling pathway ([@bib53]). In addition to its classical role as a cell stress mediator, JNK, like Notch, plays roles in multiple morphogenetic processes including proliferation, cell death, and cell shape changes ([@bib61]).

In this work, we report the results of a systematic, genome-wide modifier screen in *Drosophila* to dissect and define the genetic circuitry that interacts with Notch to affect proliferation events. We investigate the mechanism of a novel synergistic interaction via JNK between Notch and the *Drosophila* Src genes, which regulate proliferation, apoptosis, adhesion, and motility and whose human orthologs are abnormally activated in numerous types of primary and metastatic tumors ([@bib68]; [@bib55]; [@bib76]; [@bib34]; [@bib78]; [@bib21]).

Results {#s2}
=======

An unbiased genetic screen reveals that more than 300 genes potentially interact with Notch to influence proliferation {#s2-1}
----------------------------------------------------------------------------------------------------------------------

We performed a genome-wide screen for modifiers of an activated Notch (N^act^)-induced large eye phenotype to uncover novel genes that interact with Notch to affect proliferation using the Exelixis collection of insertional mutations, which covers approximately 50% of the genome ([@bib72]; [@bib33]; [@bib53]). We screened for enhancement or suppression of the large eye phenotype ([Figure 1A](#fig1){ref-type="fig"}). As a result, we identified 360 *Drosophila* genes that are predicted to affect Notch-induced proliferation in the eye; of particular interest are the 206 genes that have clear human orthologs ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). Gene Ontology (GO) analysis reveals that 42 GO categories are significantly enriched among the 360 genes ([Figure 1B](#fig1){ref-type="fig"}, and [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}). The majority of these enriched GO terms fall into three broad categories: genes involved in morphogenesis and development, genes involved in cell division and the cell cycle, and genes involved in transcription. Notably, 84 of the 360 genes did not have any associated GO or INTERPRO annotation. The majority of the genes identified in this screen have not previously been linked to Notch. For example, analysis of known and predicted interactions using the GeneMania platform between Notch and the 31 annotated cell cycle genes shows that only one (*inscuteable, insc)* was previously directly linked to Notch ([Figure 1C](#fig1){ref-type="fig"}).10.7554/eLife.05996.003Figure 1.A genetic screen for modifiers of Notch-induced proliferation in the *Drosophila* eye.(**A**) Examples of screen phenotypes. *E1\>N*^*act*^ results in larger eyes (second panel), compared to wild-type (*E1Gal4* alone) controls (top panel). Examples of three enhancers, *c01597* (fng), *c03191* (Mef2), and *d07478* (Lck), and one suppressor, *d09869* (Cad99C), are shown. (**B**) Analysis of enrichment of GO terms among the 360 *Drosophila* genes identified in the screen. Only enriched terms with corrected p-value \< 0.05 (using Benjamini--Hochberg correction) are shown. For numerical p-values, please see [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}. (**C**) Gene association analysis among cell cycle genes identified in the genetic screen. Genetic interactions, physical interactions, predicted interactions, and shared protein domains were mapped using GeneMania ([www.genemania.org](http://www.genemania.org)) between the 31 cell cycle genes from our screen (black circles) and Notch (yellow). Genes labeled with grey circles are part of the network but were not identified in our screen.**DOI:** [http://dx.doi.org/10.7554/eLife.05996.003](10.7554/eLife.05996.003)

This unbiased genetic screen reveals the unexpected complexity of the genetic circuitry capable of influencing proliferation events in combination with Notch signals.

Src overexpression alleles synergize with activated Notch {#s2-2}
---------------------------------------------------------

We previously reported that the transcription factor Mef2, a gene identified in our screen ([Figure 1A](#fig1){ref-type="fig"}), synergizes with Notch to induce hyperproliferative and metastatic effects through activation of the JNK signaling pathway ([@bib53]). We therefore asked whether any of the other genes identified in the screen might also be a component of the Notch/Mef2/JNK signaling axis. We retested 26 of the hits from the screen for JNK activation using qPCR to explore changes in expression of *puckered (puc)*, a direct JNK target ([@bib47]), and *MMP1*, an indirect target ([@bib74]), in *Drosophila* wing discs in an *MS1096Gal4; UAS-N*^*act*^ background. We found that only two of the 26 lines were able to induce both *puc* and *MMP1* ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). These two lines were *d08184* (predicted to overexpress *Eip75EF*) and *d10338* (predicted to overexpress *Src42A*). Of these two lines, *d10338* was a much stronger activator of both *puc* and *MMP1*.

The combination of *d10338* with *UAS-N*^*act*^, under the *E1Gal4* driver, results in a strong enhancement ([Figure 2A](#fig2){ref-type="fig"}) of the N^act^ large eye phenotype ([Figure 2C](#fig2){ref-type="fig"}). We also often observe outgrowths of eye tissue protruding from the borders of the eye (arrow in [Figure 2A](#fig2){ref-type="fig"}). Notably, *d10338* alone produced smaller eyes ([Figure 2B](#fig2){ref-type="fig"}) than wild-type controls ([Figure 2D](#fig2){ref-type="fig"}).10.7554/eLife.05996.004Figure 2.Synergy between Notch and Src in the eye and wing causes hyperplastic phenotypes and activates JNK.(**A**--**H**) Various *UAS-Src* constructs were driven by *E1Gal4* along with UAS-N^act^ in the developing eye. When *d10338*, an Exelixis allele that causes Gal4-dependent overexpression of Src42A, and N^act^ are coexpressed (**A**), the N^act^ large eye phenotype (**C**) is enhanced; in addition, occasional outgrowths of eye tissue can be seen (arrow). Note that d10338 alone (**B**) results in decreased eye size, whereas N^act^ alone (**C**) results in increased eye size compared to the control (**D**). Src42A^CA^ and Src64B both cause a similar phenotype (**E**, **G**) when coexpressed with N^act^ under *E1Gal4*, and both also result in decreased eye size in the absence of N^act^ (**F**, **H**). (**I**--**L**) *UAS-N*^*act*^ and *UAS-Src42A*^*CA*^ were driven in the developing wing using the *vgGal4* driver. When N^act^ and Src42A^CA^ are co-expressed (**I**), wing discs are overgrown compared to either Src42A^CA^ (**J**) or N^act^ (**K**) alone and display a characteristic 'crumpled ball' phenotype indicative of tissue disorganization and cell migration. Note that Src42A^CA^ alone (**J**) causes disorganization but not overgrowth. (**M**--**P**) *Puc-LacZ* reporter assay for JNK signal activation in wing discs expressing UAS constructs as indicated under the *vgGal4* driver in a *puc*^*E69*^*/+* background. Coexpression of N^act^ and Src42A^CA^ (**M**) causes strong, global activation of the *pucLacZ* reporter. In contrast, expression of either gene alone (**N**, **O**) causes weaker activation that is limited in scope. Scale bars: 100 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05996.004](10.7554/eLife.05996.004)10.7554/eLife.05996.005Figure 2---figure supplement 1.*d10338* is a UAS allele of *Src42A*.(**A**, **B**) U*AS-GFP/d10338; dppGal4/+* wing discs were stained for anti-phosphoY418-Src (p-Src, red), which labels activated Src. Scale bar: 100 μm. (**C**) qPCR for *Src42A* in *MS1096Gal4/+; d10338/+* wing discs (blue bar) or *MS1096Gal4/+* controls (red bar). Mean values are shown for two independent biological replicates.**DOI:** [http://dx.doi.org/10.7554/eLife.05996.005](10.7554/eLife.05996.005)10.7554/eLife.05996.006Figure 2---figure supplement 2.Src64B also synergizes with N^act^ in the wing disc.When driven with *vgGal4*, Src64B and N^act^ synergize to produce an overgrown, disorganized disc (**A**), whereas Src64B alone causes disorganization (**B**) and N^act^ alone causes large but organized discs (**C**) compared to control (**D**). Scale bar: 100 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05996.006](10.7554/eLife.05996.006)

We corroborated that gain-of-function of Src42A is indeed responsible for the synergy by repeating the eye experiment with a constitutively active *Src42A* allele (*UAS-Src42A*^*CA*^) ([@bib71]). Indeed, Src42A^CA^ also causes hyperplastic eye growth in combination with N^act^ ([Figure 2E](#fig2){ref-type="fig"}) and reduced eye size when expressed on its own ([Figure 2F](#fig2){ref-type="fig"}).

As expected, Gal4-driven expression of *d10338* results in an upregulation of both the Src42A gene product and the active, phosphorylated form of Src in *vgGal4/d10338* wing discs ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).

*VgGal4*-driven expression of *UAS-N*^*act*^ and *UAS-Src42A*^*CA*^ in the wing disc also resulted in a hyperplastic phenotype; the wing discs are not only overgrown but also noticeably disorganized, with a characteristic 'crumpled ball' phenotype ([Figure 2I](#fig2){ref-type="fig"}). Furthermore, these larvae fail to pupate and develop a 'giant larvae' phenotype. Src42A^CA^ alone causes disorganization but no increase in overall disc size ([Figure 2J](#fig2){ref-type="fig"}), whereas N^act^ alone causes increased disc size but minimal apparent disorganization ([Figure 2K](#fig2){ref-type="fig"}).

There are two distinct Src family members in *Drosophila*, *Src42A* and *Src64B*. Previous reports have shown that they are both widely expressed and may be redundant in many cases ([@bib69]; [@bib71]; [@bib70]). Therefore, we asked whether Src64B also synergizes with N^act^. Consistent with the notion that Src42A and Src64B function similarly, we find that Src64B also interacts with N^act^ to produce hyperplastic eyes with outgrowths and overgrown, disorganized wing discs ([Figure 2G](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}).

Involvement of JNK signaling {#s2-3}
----------------------------

In order to confirm that JNK signaling acts downstream of Notch and Src (henceforth N/Src), we used the *puc-LacZ* reporter to visualize JNK signal activation in vivo ([@bib47]). Coexpression of N^act^ and Src42A^CA^ in *vgGal4* wing discs results in strong, widespread LacZ expression ([Figure 2M](#fig2){ref-type="fig"}). In contrast, N^act^ or Src42A^CA^ alone each induced far weaker, spatially restricted *puc-LacZ* activation ([Figure 2N,O](#fig2){ref-type="fig"}).

Given that previous studies associated increased JNK signaling with both invasiveness and apoptosis ([@bib74]; [@bib53]), we tested for expression of MMP1, a matrix metalloprotease associated with invasive phenotypes and cleaved caspase 3 (cl-casp3), an apoptotic marker. Coexpression of N^act^ and Src42A^CA^ caused high levels of both MMP1 and cl-casp3 ([Figure 3A,G](#fig3){ref-type="fig"}). This is in striking contrast to N^act^+Mef2, which results in robust MMP1 activation but little to no apoptosis, consistent with our previous report ([Figure 3F,L](#fig3){ref-type="fig"}) ([@bib53]).10.7554/eLife.05996.007Figure 3.N/Src synergy induces both MMP1 and apoptosis.(**A**--**L**) Immunofluorescence for MMP1 (**A**--**F**) and cleaved caspase 3 (cl-casp3, **G**--**L**) in wing discs expressing UAS constructs under *vgGal4*. Together, N^act^ and Src42A^CA^ cause robust activation of both MMP1 (**A**) and cl-casp3 (**G**), which is strongly reduced by Bsk^DN^ (**E**, **K**). The combination of N^act^ and Mef2 results in an increase in MMP1 (**F**) but little effect on cc3 (**L**). (**M**) qPCR for *egr* and *wgn* in wing discs overexpressing genes as indicated under the *vgGal4* driver reveals that both transcripts are strongly downregulated when N^act^ and Src42A^CA^ are coexpressed. Scale bar: 100 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05996.007](10.7554/eLife.05996.007)10.7554/eLife.05996.008Figure 3---figure supplement 1.Gal4/UAS titration does not affect the N/Src phenotype.(**A**, **C**) One copy each of *UAS-N*^*act*^*, UAS-Src42A*^*CA*^, and *UAS-GFP* (three UAS transgenes total) were driven with *vgGal4* in the wing disc, and compared to (**B**, **D**) wing discs expressing only *UAS-N*^*act*^ and *UAS-Src42A*^*CA*^ (two UAS transgenes total) with *vgGal4*. Discs were stained for MMP1 (**A**, **B**) or cleaved caspase 3 (**C**, **D**). Scale bar: 100 μM.**DOI:** [http://dx.doi.org/10.7554/eLife.05996.008](10.7554/eLife.05996.008)10.7554/eLife.05996.009Figure 3---figure supplement 2.A heterozygous null mutation of Notch can rescue lethality and phenotype of Src alone.*N*^*55e11*^*/FM7C;UAS-Src64B* virgins were crossed to *vgGal4* males at 18°C (**A**, **B**) and the resultant female progeny were scored. *N*^*55e11*^*/+;vgGal4/UAS-Src64B* flies were more viable (**B**, n = 126 over four independent experiments) than their *FM7C/+;vgGal4/UAS-Src64B* siblings (**A**, n = 16), and show a rescued phenotype similar to that of *N*^*55e11*^*/+;vgGal4/+* controls (**C**). *FM7C/+;vgGal4/UAS-Src64B* (**A**) wings were indistinguishable from *vgGal4/UAS-Src64B* (**D**) wings. (**E**--**H**) Immunostaining for MMP1 (**E**, **G**) or cleaved caspase 3 (**F**, **H**) in wing discs with genotypes (**D**, **E**) *FM7iGFP/+;vgGal4/UAS-Src64B* or (**F**, **G**) *N*^*55e11*^*/+;vgGal4/UAS-Src64B*. Scale bar: 100 μm. (**I**--**K**) *d10338* (Exelixis *Src42A* allele) lethality and phenotype at 25°C can be partially rescued by Notch RNAi. *vgGal4/d10338* flies (**I**) are largely pupal lethal (n = 3 viable adults compared to 62 *vgGal4/CyO-Tb* siblings from the same cross) and the few escapers have no wings. In contrast, *vgGal4/d10338, UAS-N*^*RNAi*^ flies (**J**) have narrow, short, and shriveled wings and much lower lethality (n = 67, compared to 108 *vgGal4/CyO* siblings from the same cross.) The wing phenotype appears to be a more severe version of the phenotype of *vgGal4/UAS-N*^*RNAi*^ flies (**K**).**DOI:** [http://dx.doi.org/10.7554/eLife.05996.009](10.7554/eLife.05996.009)

To examine whether JNK signaling is responsible for the observed phenotypes, we used a dominant negative form of the *Drosophila* JNK gene *Basket* (*UAS-Bsk*^*DN*^) to block JNK signaling in N/Src wing discs. We found that *Bsk*^*DN*^ reduced both MMP1 and cl-casp3 to near-wildtype levels ([Figure 3E,K](#fig3){ref-type="fig"}). In order to rule out the formal possibility that the observed rescue is caused by titration of Gal4 by an additional UAS rather than by a *bona fide* effect of the Bsk^DN^ transgene, we coexpressed *UAS-N*^*act*^ and *UAS-Src42A*^*CA*^ with *UAS-GFP* and observed no discernible rescue ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}).

In our earlier work, we reported that N/Mef2 activates JNK through the TNF ligand *eiger (egr)* ([@bib53]); we therefore asked whether this is also the case for N/Src. We find that N^act^+Src42A^CA^ actually causes a synergistic downregulation of both *egr* and its receptor *wengen (wgn)*, suggesting that unlike the N/Mef2 synergy, N/Src activates JNK via a TNF-independent mechanism ([Figure 3M](#fig3){ref-type="fig"}).

Since the *vestigial (vg)* gene is known to be a target of Notch ([@bib35]), we wished to rule out the possibility that the phenotypes we observe could be complicated by an effect of N^act^ directly on the *vgGal4* driver. Therefore, we repeated the above experiment using the *dppGal4* driver, which is expressed in the anterior-posterior boundary of the wing disc. Just as with *vgGal4*, *dppGal4*-driven N^act^+Src42A^CA^ induces MMP1 and cl-casp3 in the wing disc, and this effect is rescuable by Bsk^DN^ ([Figure 4](#fig4){ref-type="fig"}). Furthermore, we included a UAS-GFP transgene in these experiments to mark the domain of transgene expression and determine whether or not the effects we see are cell-autonomous. Indeed, we find that some GFP-positive cells, notably those in the far ventral region of the disc, do not obviously express either MMP1 or cl-casp3 (green arrows in [Figure 4](#fig4){ref-type="fig"}). Additionally, some apoptosis is detected in GFP-negative domains of both N^act^+Src42A^CA^ and Src42A^CA^ wing discs (red arrows in [Figure 4](#fig4){ref-type="fig"}), suggesting a non-cell-autonomous effect, although we cannot rule out the possibility that since these cells are dying, they have also stopped expressing GFP.10.7554/eLife.05996.010Figure 4.*dpp-Gal4* driven expression of N^act^ and Src42A^CA^ also upregulates MMP1 and induces apoptosis.UAS transgenes as indicated were driven with *dppGal4* along with *UAS-GFP* at 18°C. Controls express an extra copy of *UAS-GFP*. Wing discs were stained with anti-MMP1 (**A**--**L**) or anti-cleaved caspase 3 (cl-casp3, **M**--**X**). The combination of N^act^ and Src42A^CA^ induces both MMP1 (**A**, **G**) and cl-casp3 (**M**, **S**), and Src42A^CA^ alone does the same to a lesser extent (**B**, **H**, **N**, **T**). Green arrows: GFP positive cells that do not express MMP1 (**G**, **H**) or cl-casp3 (**S**, **T**). Red arrows: cl-casp3-positive cells that do not express GFP, indicating a potentially non-cell-autonomous effect. This effect can be largely rescued with Bsk^DN^ (**E**, **K**, **Q**, **W**). Similarly, the combination of Src64B and N^act^ also induces both MMP1 (**F**, **L**) and cl-casp3 (**R**, **X**). Scale bar: 100 μM.**DOI:** [http://dx.doi.org/10.7554/eLife.05996.010](10.7554/eLife.05996.010)

These observations were also corroborated by determining that Src64B, in concert with N^act^, also strongly activates both MMP1 and cl-casp3 ([Figure 4F,L,R,X](#fig4){ref-type="fig"}). Interestingly, it appears to induce correspondingly higher levels of MMP1 and lower levels of apoptosis than Src42A^CA^; we note, however, that the Src64B allele we used is a WT allele, whereas the Src42A^CA^ is constitutively active.

Taken together, these findings reveal that Notch and Src act together to induce JNK signaling and subsequent downstream consequences such as MMP1 activation and induction of apoptosis, but that this JNK activation differs subtly from that induced by Notch and Mef2.

It is noteworthy that Src42A or Src64B alone can often generate apparently weaker versions of the N/Src synergistic phenotype ([Figures 2--4](#fig2 fig3 fig4){ref-type="fig"}). Notch is endogenously active in both the eye and wing discs during the time when the Src transgenes are expressed in our experiments ([@bib30]; [@bib7]; [@bib6]; [@bib23]). We therefore suspected that the observed effects of Src alone could be caused by synergy between exogenous Src and endogenous Notch. To test this, we used the *N*^*55e11*^ heterozygous mutation to decrease levels of endogenous Notch in the developing wing. When *UAS-Src64B* is driven by *vgGal4* in a wild-type background (*FM7C/+;vg-Gal4/UAS-Src64B*), we observe a high degree of lethality, with the few escapers (n = 16 over four independent experiments) displaying small, shriveled, vestigial wings. In contrast, *N*^*55e11*^*/+;vgGal4/UAS-Src64B* siblings demonstrated reduced lethality (n = 126) and fully extended, notched wings similar to the notched wing phenotype of *N*^*55e11*^*/+;vgGal4/+* controls ([Figure 3---figure supplement 2A--D](#fig3s2){ref-type="fig"}). MMP1 and cl-casp3 induced by Src64B were also significantly reduced in *N*^*55e11*^*/+;vgGal4/UAS-Src64B* wing discs ([Figure 3---figure supplement 2E--H](#fig3s2){ref-type="fig"}).

A similar rescue occurs when we combine the *d10338* Src42A allele with *UAS-Notch*^*RNAi*^ *(N*^*RNAi*^). *d10338* alone, when driven with *vgGal4*, is largely lethal, with the few escapers (n = 3, compared to 62 balancer siblings) having only wing stumps. In contrast, when *UAS-N*^*RNAi*^ is added, lethality is largely rescued (n = 67, vs 108 balancer siblings) and the wings form long, thin spikes similar to those generated by *N*^*RNAi*^ alone ([Figure 3---figure supplement 2I--K](#fig3s2){ref-type="fig"}).

We finally note that the above experiment does not rule out the possibility that the observed rescue could be caused by an effect of *N*^*55e11*^*/+* or *UAS-N*^*RNAi*^ on the *vgGal4* driver itself. Unfortunately, attempts to repeat these experiments using other Gal4 drivers (*C96Gal4* or *dppGal4*) or Src-activating mutants (*Csk*^*j1d8/j1d8*^ or *Csk*^*j1d8/+*^*, puc*^*E69/+*^ \[[@bib39]\]) were unsuccessful due to high levels of lethality.

N/Src synergy perturbs the cell cycle {#s2-4}
-------------------------------------

The cell cycle is often misregulated during hyperplastic or cancerous growth. We thus performed a DNA content analysis to examine the cell cycle distribution of GFP-positive cells from *vgGal4;UAS-GFP* wing discs expressing Src64B and N^act^. Whereas wild type and N^act^ cells have 23% and 25% of cells in G1 phase respectively, N^act^+Src64B cells showed a complete loss of G1 phase. Src64B alone caused a partial loss of G1 phase (4%). In both cases, a corresponding increase in the proportion of S phase cells was also observed. The effect on the cell cycle appears to be dependent on JNK signaling, as blocking JNK with Bsk^DN^ strongly reversed the G1 bypass (19% of cells in G1). Both Src42A alleles (Src42A^CA^ and d10338) produced cell cycle distribution profiles (2% and 3% in G1 phase respectively) similar to Src64B when coexpressed with N^act^. Likewise, wing disc cells coexpressing N^act^ and Mef2 displayed a decreased number of cells in G1 phase (5%) ([Figure 5A](#fig5){ref-type="fig"}). Cells from *dppGal4;UAS-GFP* wing discs, similar to those from *vgGal4; UAS-GFP* discs, coexpressing Src64B and N^act^ also displayed a similar, JNK-dependent loss of the G1 peak ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).10.7554/eLife.05996.011Figure 5.N/Src synergy disrupts the cell cycle.(**A**) DNA content analysis was performed on Hoechst-labeled dissociated cells from *vgGal4;UAS-GFP* wing discs expressing *UAS-Src64B;UAS-N*^*act*^ (dark green trace), *UAS-Src64B* (light blue), *UAS-N*^*act*^ (red), WT control (black), *UAS-Bsk*^*DN*^*;UAS-Src64B;UAS-N*^*act*^ (light green), *UAS-N*^*act*^*;UAS-Src42A*^*CA*^ (purple), *UAS-N*^*act*^;*d10338* (dark blue) or *UAS- N*^*act*^;*UAS-Mef2* (orange). Comparative histograms show relative frequencies on the y-axis, normalized to total number of counts for each sample. (**B**--**E**) EdU incorporation assay in *dppGal4;UAS-GFP* wing discs expressing *d10338;UAS-N*^*act*^ (**B**), *d10338* (**C**), *UAS-N*^*act*^ (**D**), or *UAS-GFP* (**E**) at 22°C. A closeup of the areas denoted by boxes is shown below each image, and the GFP-positive area is marked with dotted yellow lines. Whereas *UAS-N*^*act*^ alone expands the ZNC (zone of non-proliferating cells) and also non-cell-autonomously induces proliferation in the dorsal-posterior region of the disc, thus increasing the size of the dorsal compartment (**D**), the combination of *d10338* and *UAS-N*^*act*^ eliminates the expansion of the non-proliferative zone and causes cells within the ZNC proper to begin incorporating EdU; furthermore, the area of increased proliferation in the dorsal compartment appears to be expanded (**B**). (**F**--**J**) N^act^ and Src42A^CA^ together cause a reduction in *dacapo (dap)* levels. (**F**) qPCR for *dap* expression in wing discs expressing N^act^ and/or Src42A^CA^ or Mef2 under the *vgGal4* driver. (**G**--**J**) A *dap-LacZ* reporter assay was used to visualize *dap* expression in *vgGal4* wing discs in a *dap*^*k07309*^*/+* background. Both N^act^ and Src42A^CA^ together (**G**) and Src42A^CA^ alone (**H**) show a reduction in dap-LacZ compared to both N^act^ alone (**I**) and *vgGal4* controls (**J**). Scale bars: 100 μM.**DOI:** [http://dx.doi.org/10.7554/eLife.05996.011](10.7554/eLife.05996.011)10.7554/eLife.05996.012Figure 5---figure supplement 1.Elimination of G1 phase of the cell cycle also occurs in *dppGal4* wing discs expressing N^act^ and Src64B.DNA content analysis was performed on Hoechst-labeled dissociated cells from *dppGal4;UAS-GFP* wing discs expressing *UAS-Src64B;UAS-N*^*act*^ (green trace), *UAS-Src64B* (blue), *UAS-N*^*act*^ (red), WT control (grey), or *UAS-Bsk*^*DN*^*;UAS-Src64B;UAS- N*^*act*^ (yellow-green). Comparative histograms show relative frequencies on the y-axis, normalized to total number of counts for each sample.**DOI:** [http://dx.doi.org/10.7554/eLife.05996.012](10.7554/eLife.05996.012)

Cell cycle arrest in G1 phase is a hallmark of cells in the Zone of Non-proliferating Cells (ZNC) located in the D-V boundary of the wing disc ([@bib30]). If N/Src could cause G1 bypass, then, we reasoned, it might also cause ZNC disruption. We visualized the ZNC by incorporating EdU, which labels cells in S phase, in *dppGal4;UAS-GFP* wing discs. We used the *d10338* Src42A allele, as the more modest disruption of disc organization caused by this weaker allele allowed us to better identify the ZNC. Control ZNC cells that are arrested in G1 do not enter S phase and therefore do not incorporate EdU ([Figure 5E](#fig5){ref-type="fig"}); N^act^ alone causes ZNC expansion and a partially non-cell autonomous increase in EdU incorporation in the dorsal region of the disc ([Figure 5D](#fig5){ref-type="fig"}), as previously reported ([@bib19]; [@bib30]; [@bib23]). In contrast, discs expressing N^act^ and d10338 show a reduced ZNC with correspondingly more EdU-labeled cells in the D--V boundary, and the area of Notch-induced increased proliferation in the dorsal region is expanded, extending all the way down to the ZNC and greatly increasing the size of the dorsal compartment ([Figure 5B](#fig5){ref-type="fig"}).

Given that the cyclin-dependent kinase (CDK) inhibitor *dacapo (dap)* blocks G1 to S transition and is important for cell cycle exit in G1 ([@bib13]; [@bib38]) we asked whether N/Src affects transcription of *dap*. qPCR reveals that N^act^+Src42A^CA^ expression is indeed associated with a downregulation of both Notch-induced and endogenous *dap* transcription; we note that N^act^+Mef2 similarly reduced *dap* levels, although to a lesser extent ([Figure 5F](#fig5){ref-type="fig"}). We corroborated the qPCR result using the *dap*^*k07309*^ enhancer trap line, which functions as a *dap-LacZ* reporter ([@bib49]). N^act^ alone activates *dap-LacZ*, and N^act^+Src42A^CA^ suppresses not only this increase but also the endogenous expression of the reporter ([Figure 5G,I,J](#fig5){ref-type="fig"}). Src42A^CA^ alone also causes a significant decrease in reporter expression ([Figure 5H](#fig5){ref-type="fig"}).

We conclude that N/Src synergy results in bypassing the G1 phase of the cell cycle, likely via the downregulation of the CDK inhibitor *dacapo.*

JNK and JAK/STAT signaling pathways are downstream of N/Src synergy {#s2-5}
-------------------------------------------------------------------

Disorganized, hyperplastic growth has been associated with JAK/STAT signaling in *Drosophila*; furthermore, both Src and Notch individually can activate JAK/STAT ([@bib71]; [@bib59]; [@bib60]). We thus probed whether N/Src expression could affect JAK/STAT signaling.

To assess JAK/STAT signal activation, we used qPCR to measure expression levels of the JAK/STAT ligands *unpaired/outstretched (upd/os), unpaired2 (upd2), and unpaired 3 (upd3).* We found that all three *upd* genes were strongly upregulated in a synergistic manner by N^act^+Src42A^CA^; furthermore, this upregulation was largely suppressed by the addition of Bsk^DN^, indicating that it is dependent on JNK signals. N^act^+Mef2 also activated the *upd* ligands, but to a far lesser extent ([Figure 6A](#fig6){ref-type="fig"}). An *upd-LacZ* reporter line reveals similar results, with the combination of *UAS-N*^*act*^ and *UAS-Src42A*^*CA*^ driven by *vgGal4* inducing strong reporter activation compared to either gene alone or controls expressing *vgGal4* alone ([Figure 6B--E](#fig6){ref-type="fig"}).10.7554/eLife.05996.013Figure 6.N/Src synergy activates the JAK/STAT signaling pathway.(**A**) qPCR for *unpaired* family ligands in *vgGal4* discs expressing UAS constructs as indicated. All three *upd* family genes are highly upregulated by the combination of N^act^ and Src42A^CA^ (dark purple bars), and this upregulation is dependent upon JNK signaling as Bsk^DN^ rescues it (lavender bars). Coexpression of N^act^ and Mef2 (orange bars) induces a much lower level of the *upd* ligands. Note that the y-axis is on a logarithmic scale. (**B**--**E**) An *upd-LacZ* reporter assay in *vgGal4* wing discs validates the qPCR data and demonstrates that N^act^+Src42A^CA^ causes strong, widespread activation of *upd* transcription (**B**); in contrast, either gene alone (**C**, **D**) causes lower, more restricted levels of *upd* upregulation. (**F**--**J**) The *10XStatGFP* reporter was used to assess JAK/STAT signal activation in *vgGal4* discs grown at 18°C. N^act^+Src42A^CA^ strongly upregulates *10XStatGFP* (**G**), whereas either gene alone (**H**, **I**) only weakly upregulates the reporter. The addition of Bsk^DN^ (**F**) reduces the *10XStatGFP* induced by N^act^+Src42A^CA^ (**G**) to levels similar to those of N^act^ alone (**I**). Note that since the *upd-LacZ* discs were grown at 25°C and the *10XSTATGFP* discs were grown at 18°C, the latter displays a somewhat weaker phenotype, hence the difference in disc size between **B**/**D** and **G**/**I**. Scale bar: 100 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05996.013](10.7554/eLife.05996.013)

To directly visualize JAK/STAT signal activation in vivo, we used the *10XSTATGFP* reporter ([@bib5]). We find that, whereas Src42A^CA^ or N^act^ alone each caused weak *10XSTATGFP* activation, the combination of the two resulted in strong reporter activation throughout the disc ([Figure 6G--J](#fig6){ref-type="fig"}). Notably, the patterns of expression of *10XSTATGFP* and *upd-LacZ* are similar. Moreover, consistent with the observation that blocking JNK reduces the expression of the *upd* genes, Bsk^DN^ also reduced *10XSTATGFP* reporter activation ([Figure 6F](#fig6){ref-type="fig"}).

Thus, N/Src synergy results in activation of JAK/STAT signaling by the upregulation of the *upd* ligands in a JNK-dependent manner.

Identification of downstream targets of N/Src synergy {#s2-6}
-----------------------------------------------------

To examine the gamut of transcriptional targets downstream of N/Src coexpression, we performed an RNA-sequencing (RNA-seq) analysis in *vgGal4* wing discs. We defined 'synergistic targets' as those genes that were significantly up- or down-regulated (adjusted p-value \< 0.05) in N^act^+Src42A^CA^ discs as compared to N^act^ alone, Src42A^CA^ alone, or WT controls. By these criteria, we identified 187 genes, of which 87 were downregulated and 100 were upregulated; the effects on expression of 130 of these genes was reversed by Bsk^DN^ ([Supplementary file 3](#SD3-data){ref-type="supplementary-material"}), consistent with the notion that their expression is dependent on JNK. We validated 44 of these genes with qPCR; 4/44 were thus determined to be false positives. We note that of these 187 *Drosophila* genes, 120 have clear human orthologs ([Supplementary file 3](#SD3-data){ref-type="supplementary-material"}).

It is noteworthy that this analysis did not uncover several known N/Src targets (the *upd* genes, *MMP1*, *puc,* and *dap*). We attribute this to the observation that Src alone often causes a milder version of the N/Src phenotype; our analysis is not always sensitive enough to assign significance to relatively small N/Src vs Src differences. For *MMP1, os/upd, upd2,* and *upd3,* the raw data reveals that the N/Src vs Src comparison was small enough to be insignificant, although *upd2* and *upd3* appeared significant prior to false positive correction. For *dap,* we observe a reduction of Notch-induced *dap* with the addition of Src42A^CA^; however, we did not detect the same reduction in endogenous *dap* between N/Src and WT discs that we saw with qPCR and the *dap-LacZ* reporter. We cannot at present explain this discrepancy. Finally, *puc* did not score as a significant target in our analysis, possibly due to a false positive reading in the RNA-seq data for the WT condition, as there is no evidence to suggest that *puc* is highly upregulated in WT discs ([Supplementary file 4](#SD4-data){ref-type="supplementary-material"}).

One synergistically upregulated gene was *Enhancer of split mγ (E(spl)mγ* or *HLHmgamma*)*,* a member of the *E(spl)* complex and a target of Notch itself. We therefore asked whether other *E(spl)* complex members were similarly affected. Six of the seven members (excepting *E(spl)m5*) are expressed in the wing disc. However, only *E(spl)mγ* was synergistically upregulated. The other five expressed genes in the locus *(E(spl)m8, E(spl)m3, E(spl)m7, E(spl)mβ*, and *E(spl)mδ*) were, as expected, upregulated by N^act^ alone, but, interestingly, this upregulation actually appeared to be suppressed by the addition of Src, sometimes all the way back to WT levels; Bsk^DN^ reversed both the N/Src-induced enhancement of *E(spl)mγ* (albeit weakly) and the suppression of the other five *E(spl)* genes ([Figure 7A](#fig7){ref-type="fig"}). In contrast, N^act^+Mef2 caused suppression of all of the *E(spl)* genes, including *E(spl)mγ* ([Figure 7A](#fig7){ref-type="fig"}). We corroborated these observations by using an *E(spl)mγ* reporter consisting of a 234-bp mγ enhancer region, which has been shown to recapitulate the endogenous *E(spl)mγ* expression pattern in the wing disc, fused to LacZ ([@bib50]). While, as expected, N^act^ causes an increase in the number of cells that express *E(spl)mγ-LacZ*, N^act^+Src42A^CA^ does not; interestingly Src42A^CA^ alone eliminates the endogenous pattern of *E(spl)mγ-LacZ*, possibly due to cell death ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). This observation raises the possibility that E(spl)mγ activation by N/Src is driven by a genomic region distinct from the 234-bp mγ enhancer region.10.7554/eLife.05996.014Figure 7.Notch targets are differentially affected by N/Src synergy.(**A**) qPCR assay for expression levels of *E(spl)* complex members in *vgGal4* wing discs expressing UAS constructs as indicated. (**B**--**E**) Immunostaining with anti-cut (red) in *vgGal4* wing discs. N^act^ alone (**D**) induces cut expression, which is suppressed in N^act^+Src42A^CA^ discs (**B**). Note that both ectopic and endogenous cut appear to be suppressed. (**F**) NRE-GFP expression in wing discs expressing N^act^+Src42A^CA^ under *vgGal4*. Scale bar: 100 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05996.014](10.7554/eLife.05996.014)10.7554/eLife.05996.015Figure 7---figure supplement 1.E(spl)mγ reporter staining in N/Src wing discs.*VgGal4* wing discs expressing *UAS-N*^*act*^ and/or *UAS-Src42A*^*CA*^ in an *E(spl)mγ-LacZ/+* background were stained for anti-β-gal. *E(spl)mγ-LacZ* consists of the 234-bp *mγ* enhancer region fused to a LacZ reporter ([@bib50]). Note that E(spl)mγ induced by N^act^ (**C**) is not suppressed by the addition of Src42A^CA^ (**A**). Src42A^CA^ alone (**B**) seems to suppress the endogenous E(spl)mγ staining (**D**) in the proneural cells.**DOI:** [http://dx.doi.org/10.7554/eLife.05996.015](10.7554/eLife.05996.015)

Because the *E(spl)* complex is an important Notch target, we asked whether the expression pattern of *cut*, another well-known Notch target, was affected by N/Src. As expected, cut staining was upregulated in a broad swath when N^act^ alone was driven by *vgGal4* ([Figure 7D](#fig7){ref-type="fig"}). Strikingly, this ectopic cut expression appeared to be completely absent in N^act^+Src42A^CA^ wing discs ([Figure 7B](#fig7){ref-type="fig"}). Furthermore, even endogenous cut disappeared in both N^act^+Src42A^CA^ ([Figure 7B](#fig7){ref-type="fig"}) and Src42A^CA^ ([Figure 7C](#fig7){ref-type="fig"}) wing discs. Thus, cut is not upregulated like *E(spl)mγ* by N/Src, but rather suppressed like the other five *E(spl)* genes.

Since the major downstream effector of Notch is *Suppressor of Hairless (Su(H))* exerting its action by binding to Notch-dependent promoter sites, we asked if the NRE-GFP reporter, which is activated by Notch binding to Su(H) sites, could be activated by N/Src. We find that N^act^+Src42A^CA^ is still able to strongly activate the NRE-GFP reporter ([Figure 7F](#fig7){ref-type="fig"}).

These analyses demonstrate that N/Src synergy affects a diverse set of genes largely in a JNK dependent manner, including known Notch targets, which however seem to be differentially regulated.

Discussion {#s3}
==========

The developmental outcome of a signaling pathway depends upon how the signal integrates with other pathways and factors within and between cells. Given that Notch defines an essential, ancient, and highly pleiotropic developmental pathway, it is plausible that the genetic circuitry that has evolved to influence the biological outcome of Notch signals is complex. The present analysis highlights the complexity and, significantly, the subtlety of Notch signal synergies. We focused our attention here on N/Src synergy partly because the proliferation phenotype we monitor depends, like our previously reported N/Mef2 synergy ([@bib53]), on the activation of JNK signals. Importantly, however, we demonstrate that N/Src both accesses and interprets JNK signals in a manner distinct from that of N/Mef2. This sort of differential access to the same pathway to effect developmental outcomes may serve as a paradigm of the integration of a pleiotropic signal, such as Notch, with diverse, context-dependent factors. In turn, understanding the mechanisms of signal integration has profound implications for both normal development and disease.

Notch interacts with a large, diverse cohort of genes to control proliferation {#s3-1}
------------------------------------------------------------------------------

Notwithstanding the fact that the genetic circuitry surrounding Notch signals is very complex ([@bib22]), we were surprised to find such an abundance and diversity of genes that can cooperate with activated Notch signals to modulate cellular proliferation, a fact that has obvious potential consequences for oncogenesis as well as normal development.

It is important to note that our screen is not saturating because the Exelixis mutant collection disrupts only approximately 53% of the fly genome and has other inherent limitations, which have been described in detail elsewhere ([@bib72]; [@bib33]). In the current screen, we tested all lines (with the exception of insertions on the X chromosome, which would be hemizygous in male progeny) heterozygously, so weaker or recessive effects may not be observed. We also did not score combinations that were 100% lethal. Therefore, we do not expect to find every member of a complex or pathway or all redundant genes. In light of the above information, we presume that the true number of genes that can modify Notch-induced proliferation phenotypes is far greater (perhaps at least double) than the 360 we have identified in this work, indicating a surprising complexity and diversity of the potential genetic circuitry that can, in conjunction with Notch signals, affect proliferation.

Despite the diversity of the identified gene set, there are nevertheless some commonalities. Most notably, 31 genes are annotated as cell cycle genes, representing a more than twofold enrichment. In particular, genes involved in mitosis are highly represented. Given the phenotypic parameters of the screen, it is not surprising that cell cycle genes have been identified as modifiers. Interestingly, we identified *nanos* (*d06728*, which is predicted to be a GOF allele) as a suppressor of the large eye phenotype. This finding is corroborated by the observation that nanos can directly repress *Cyclin B (CycB)* in the germline, thereby preventing mitosis ([@bib32]). However, we also identified *c04775*, a predicted disruption of *Cyclin B3 (CycB3)*, as an enhancer; the evidence would suggest that loss of mitotic cyclins should, like *nanos* GOF, suppress rather than enhance hyperplasia. It is conceivable that this may point to a context-specific feedback regulation that, if indeed true, may have implications for oncogenesis. Such an interesting possibility, however, awaits experimental corroboration especially in view of the fact that additional analysis would be necessary to ensure that *c04775* is indeed a true loss-of-function mutation of *CycB3.*

We should also note that the screen did not always identify plausibly predicted genes. For example, *CycB*, which acts redundantly with *CycB3* in embryogenesis ([@bib41]), was not identified in our screen despite there being three predicted alleles in the Exelixis collection. On a similar note, we identified *Bub1 (c04512)* as a strong enhancer, but not any of the other key components of the spindle assembly checkpoint (*BubR1*, *Mad2*, and *Bub3)* ([@bib40]), even though they are represented in the Exelixis collection.

We cannot at present say if these observations imply some specificity of the Notch response for CycB3 and Bub1 or whether they simply reflect limitations of our screening system.

The N/Src and N/Mef2 synergies converge on JNK but diverge in downstream output {#s3-2}
-------------------------------------------------------------------------------

Previous studies have demonstrated colocalization of Notch and c-Src proteins in pancreatic cancer cells, where Src is required for proteolytic activation of Notch ([@bib46]), and of Notch and the T-cell-specific Src family member Lck in T cells ([@bib64]), but a functional relationship between the two genes had not been demonstrated prior to our study. Given that the majority of N/Src phenotypes and changes in almost 70% of the transcriptional targets can be effectively reversed upon JNK inhibition it seems clear that the major target of the N/Src synergy is the JNK pathway. Our previously reported N/Mef2 synergy activates JNK via the TNF ligand *egr* ([@bib53]), which is clearly not the case for N/Src, which actually causes suppression of both *egr* and its receptor. Additionally, N/Src causes a great deal of apoptosis, whereas N/Mef2 does not, and only N/Src is capable of differentially upregulating *E(spl)mγ*. Finally, although both combinations activate JAK/STAT ligands, the degree of upregulation is more than an order of magnitude greater for N/Src vs N/Mef2. These observations suggest that while JNK activation may be a common thread in Notch-related hyperplastic phenotypes, there may be multiple routes through which a single pathway (JNK) is activated, and this difference in access may subsequently contribute to differential downstream outputs ([Figure 8](#fig8){ref-type="fig"}).10.7554/eLife.05996.016Figure 8.Model of convergence and divergence of the Notch/Mef2/JNK and Notch/Src/JNK signaling axes.N/Mef2 and N/Src synergies converge on JNK, through *eiger*-dependent and *eiger*-independent means respectively. Some downstream processes are common to both synergies, such as MMP1 activation and bypass of G1 phase of the cell cycle via *dap* downregulation. Other downstream outputs, such as apoptosis, level of JAK/STAT activation, and regulation of Notch target genes, diverge between N/Src and N/Mef2 synergy.**DOI:** [http://dx.doi.org/10.7554/eLife.05996.016](10.7554/eLife.05996.016)

It is worth noting that the Notch/JNK signaling axis may represent a primary pathway through which the cell can not only regulate proliferation but may also affect cell movement. Two groups have recently reported a role for actin polymerization upstream of JNK activation by Src ([@bib16]; [@bib62]); given that we observed increased actin in N/Mef2 tissues ([@bib53]), we suggest that the same may be true for the N/Src axis.

In addition to N/Src and N/Mef2, a third Notch synergy that acts through JNK has been reported: the loss of the epithelial polarity gene *scribble (scrib)* induces JNK activation leading to cell death; however, in the presence of active Notch, *scrib* mutant cells instead overgrow and become invasive ([@bib11]). Whether N/scrib converges with either N/Src or N/Mef2 or defines a third JNK-dependent axis remains to be seen.

The vast diversity of signal outputs suggests that signal integration may occur not only at the level of Notch interactions but also at the level of JNK. Although the determinants of such specificity remain to be identified, we consider our identification of N/Src transcriptional targets to be a starting point for future studies.

The differential regulation of Notch targets is a specific response to N/Src {#s3-3}
----------------------------------------------------------------------------

Overexpression of Notch alone causes local expansion of the ZNC and distant hyperproliferation ([@bib30]; [@bib23]). However, our data indicate that the combination of Notch and Src actually leads to loss of the ZNC and expansion of the hyperproliferative zone, suggesting that Src modulates the activity of Notch in this situation and leads to proliferation rather than differentiation (as is also implied by the loss of cut in the D--V boundary). Our observation of differential regulation of the *E(spl)* complex genes supports the notion that Src modulates the target specificity of Notch. The NRE-GFP reporter is strongly upregulated by N/Src (similar to Notch alone), suggesting that whatever leads to suppression of Notch targets in the presence of Src either does not affect Su(H) binding or requires the modulatory action of additional, differentially acting factors.

Altered cell cycle profile as a result of N/Src synergy {#s3-4}
-------------------------------------------------------

Among the most striking N/Src phenotypes are the complete loss of the G1 phase of the cell cycle and an immense degree of hyperplasia. Our observation that the cell cycle regulator *dap* is downregulated by N/Src and N/Mef2 suggests a potential mechanism for the G1 bypass. The G1 phase is important during normal development and homeostasis to allow newly-divided cells to increase in size and replenish protein and energy stores; additionally, regulatory checkpoints during G1 control cell fate choices such as the decision to exit the cell cycle and differentiate ([@bib41]; [@bib24]). *Dap* is a member of the p21/p27 family of Cdk inhibitors, and is required during *Drosophila* embryogenesis for proper timing of cell cycle exit at G1 ([@bib13]; [@bib38]).

Early *Drosophila* embryos undergo their first 16 cell divisions without G1 or G2, resulting in rapid cell division without a corresponding increase in compartment size ([@bib41]). In contrast, we observe hyperplasia of N/Src wing discs, indicating that compartment growth must occur even in the absence of a detectable G1 phase. In the case of Ras or Myc overexpression, the other phases of the cell cycle are prolonged to compensate for decreased time in G1, and the overall growth rate also increases ([@bib31]; [@bib56], [@bib57]). We do observe an increase in the percentage of N/Src cells in S phase, suggesting that the lack of G1 is at least partially compensated for by a longer S.

The N/Src cell cycle profile, with absent G1 and a high proportion of cells in S phase, is reminiscent of that of mammalian embryonic stem cells (ESCs), which have an abbreviated G1 and longer S; recent studies have suggested that this altered cycle is necessary to maintain pluripotency, although the mechanisms are still unclear ([@bib52]; [@bib24]). Like ESCs, N/Src cells remain in an actively proliferating state rather than undergoing G1 arrest followed by differentiation. Therefore, this raises the very interesting possibility that N/Src synergy may interfere with cell fate determination, conferring pluripotency. This could have important implications for tumorigenicity as well as for the maintenance of a differentiated state. A recent report found that Src42A and Src64B in *Drosophila* intestinal stem cells (ISCs) could stimulate the expansion of a transit-amplifying population of Notch-positive cells ([@bib37]). In light of our findings, we suggest that Src may actually interact with Notch in this cell population to induce proliferation. It will therefore be informative to compare our list of N/Src transcriptional targets with the genes induced by Src in ISCs or other pluripotent cell types in both mammals and flies.

Implications for cancer biology {#s3-5}
-------------------------------

Several previous studies have shown that Src acts through JNK to induce invasive phenotypes, including activation of MMP1 ([@bib45]; [@bib62]). However, invasiveness is only one part of the oncogenic equation. Once they have migrated into a tissue, metastatic cells also need to grow and proliferate, preferably in an unchecked fashion. Our work suggests that the addition of Notch promotes hyperplastic growth while still retaining and perhaps even enhancing Src-driven invasive behavior. Strikingly, this occurs even in the presence of significant amounts of apoptosis. Should an additional mutation or gene activation occur that suppresses this cell death, the N/Src cells may become even more malignant. A clue might be found in the comparison with N/Mef2, where tissues overgrow but very little cell death is observed.

Other studies have reported that loss of the Src antagonist Csk in the wing disc can induce activation of JNK and JAK/STAT signaling as well as morphological disorganization ([@bib59]; [@bib75]; [@bib39]; [@bib76]). We hypothesize that these Csk phenotypes may result from activation of endogenous Src, which then interacts with endogenous Notch. The Src family members *Src*, *Fyn*, and *Yes* in mammals, as well as *Src42A* and *Src64B* in *Drosophila*, are widely, even ubiquitously expressed, and kept in check partly by the similarly widespread expression of *Csk* ([@bib69]; [@bib71]; [@bib70]; [@bib78]). Notch is likewise expressed in a large number of tissues ([@bib4]; [@bib3]).

Interestingly, although the activity and levels of both Src and Notch are often increased in cancers, activating mutations in the genes themselves are rare ([@bib29]; [@bib58]; [@bib44]). One explanation suggested by our data is that synergy between even relatively low levels of active Notch and Src can activate JNK and cause exponentially increased levels of hyperplastic growth and stimulation of oncogenic events. Additionally, an inactivating mutation in Csk could have devastating consequences in both development and cancer by triggering a Notch/Src synergistic response.

Among the human orthologs of our N/Src targets, genes involved in metabolism and stress response are both overrepresented. Thus these cells may have an increased metabolic rate (which may also explain the observed overgrowth in the absence of G1) and heightened protection from stress, both of which could contribute to a favorable environment for oncogenesis. In particular, this may explain how N/Src cells survive and indeed hyperproliferate despite the strong pro-apoptotic JNK signal.

An earlier study revealed that activated Notch could act as a tumor suppressor in v-Src-transformed quail neuroepithelial cells, causing a reversion of the transformed phenotype along with suppression of JNK signaling ([@bib48]). This report may seem on the surface to contradict our findings. However, Notch can act as either an oncogene and a tumor suppressor depending on context ([@bib42]). Here, too, context, including other genes that interact with the N/Src axis, is likely to be essential; further analysis of the hits from our genetic screen may shed light on this issue as well as on the larger question of how Notch switches between oncogenic and tumor suppressive behavior.

Our observation that the N/Mef2 and N/Src synergies both activate the same pathway (JNK) but display differences in downstream phenotype suggests that it may be possible to identify targeted, refined signatures for different types of Notch, Src, and JNK-related cancers.

While single gene mutations can occasionally trigger an oncogenic state, it is more often the context-dependent interplay between genes that causes or modulates cancerous growth. Understanding the mechanistic consequences of cross-talking gene activities is essential if we are to unveil the molecular basis of oncogenic events and develop rational therapeutic interventions.

Materials and methods {#s4}
=====================

Fly strains {#s4-1}
-----------

Crosses were carried out at 25°C under standard conditions unless otherwise noted. Exelixis lines used in this work can be obtained at <https://drosophila.med.harvard.edu/> ([@bib2]; [@bib54]; [@bib72]). Other fly lines used were: *UAS-N*^*act*^ ([@bib19]), *UAS-Src42A*^*CA*^ ([@bib71]), *UAS-Src64B* ([@bib51]), *puc*^*E6*9^ ([@bib47]), *UAS-Bsk*^*DN*^ ([@bib1]), *upd-LacZ* (gift from N Perrimon)*, dap*^*k07309*^ ([@bib49]), *10XStatGFP* ([@bib5]), *N*^*55e11*^ ([@bib63]), *E(spl)mγKX-LacZ* ([@bib50])*, NRE-GFP* ([@bib65]), *UAS-Mef2* ([@bib9]), and *UAS-Notch*^*RNAi*^ ([@bib25]). Gal4 lines used were *E1Gal4* (gift from G Rubin \[[@bib53]\]), *vgGal4*, *MS1096Gal4* and *dppGal4* (all available from the Bloomington *Drosophila* Stock Center, Bloomington, IN).

Antibodies and staining {#s4-2}
-----------------------

Immunostaining and EdU staining were performed as described in our previous work ([@bib53]). The following primary antibodies were used: 3A6B4 anti-MMP1 (1:100; Developmental Studies Hybridoma Bank (DSHB), Iowa City, IA), anti-cleaved caspase 3 (1:300; Cell Signaling Technology, Danvers, MA), D5.1 anti-GFP (1:300; Cell Signaling Technology), anti-β-gal (1:1000-1:2000, MP Biomedicals, Santa Ana, CA), anti-Src-pY418 (1:1000, Abcam, Cambridge, MA) and 2B10 anti-cut (1:10, DSHB). AlexaFluor conjugated secondary antibodies (Life Technologies, Carlsbad, CA) were used at 1:1000. Fluorescence microscopy (with the exception of the EdU incorporation assay) was performed on a Zeiss Axioplan microscope with a 10× objective and images were minimally processed using Adobe Photoshop CS5. The discs for the EdU incorporation assay ([Figure 5](#fig5){ref-type="fig"}) were imaged using a Nikon TE2000 with C1 Point Scanning Confocal at the Nikon Imaging Center at Harvard Medical School.

Genetic screen {#s4-3}
--------------

*UAS-N*^*act*^*/CyO-tub-Gal80; E1Gal4* fly stocks were generated and virgins were crossed to males from each line in the Exelixis mutant collection ([@bib2]; [@bib72]; [@bib53]) to screen for enhancers and suppressors of the Notch-induced large eye phenotype. All positive hits were rescreened a second time to eliminate false positives; furthermore, they were crossed to E1Gal4 alone to eliminate Notch-independent effects. We identified 332 Exelixis lines that either enhanced or suppressed the large eye phenotype. The determination of genes predicted to be affected by each Exelixis line was performed as previously described ([@bib66]). In some cases, more than one gene may be affected either due to multiple insertions or to insertion of an element in or near overlapping or neighboring genes. Mapping of *Drosophila* genes to human orthologs was performed using tables generated by Mark Gerstein\'s group at Yale University, where *Drosophila*-human ortholog pairs were identified based on three sources---InParanoid, OrthoMCL and TreeFarm (<http://info.gersteinlab.org/Ortholog_Resources>). Here, we provide only the top human ortholog (identified by the most number of sources) for each *Drosophila* gene. GO term enrichment analysis was performed using DAVID (<http://david.abcc.ncifcrf.gov/>) with the total Exelixis gene list as background; statistical significance was determined using the Benjamini--Hochberg correction. The interaction map shown in [Figure 1C](#fig1){ref-type="fig"} was generated using GeneMania ([www.genemania.org](http://www.genemania.org/)), using all available default datasets for genetic interactions, physical interactions, predicted interactions, and shared protein domains, and a limit of 20 related genes.

DNA content analysis {#s4-4}
--------------------

Wing discs from wandering third instar larvae were collected in 1× PBS and dissociated in 9× Trypsin-EDTA (Life Technologies) with 0.5 μg/ml Hoechst 33,342 and 1× PBS for approximately 4 hr at room temperature with gentle agitation ([@bib12]). FACS was performed on dissociated cells using a BD FACSAria II SORP UV, and data was analyzed using FlowJo and ModFit software.

qPCR {#s4-5}
----

Total RNA for qPCR was extracted from wing discs from wandering third instar larvae. Discs were isolated in PBS and RNA was extracted using TRIzol reagent (Life Technologies); gDNA was removed and RNA was cleaned up using the RNEasy plus micro kit (Qiagen, Valencia, CA). cDNA was generated using the High Capacity RNA to cDNA kit (Life Technologies). All qPCR reactions were performed in technical triplicate using Taqman assays (Life Technologies) on a Life Technologies 7900HT machine. Unless otherwise noted, at least three biological replicates were performed for each genotype.

RNA-seq {#s4-6}
-------

*VgGal4* females were crossed to males from the UAS lines of interest. Total RNA for RNA-seq was isolated and purified as for qPCR from at least 60 wing discs per sample. All samples were run in biological triplicate. Ribosomal RNA depletion was performed using the Ribo-zero rRNA removal kit (Epicentre, Madison, WI). Library preparation using the PrepX SPIA RNA-seq kit (IntegenX, Pleasanton, CA), library quality control, and sequencing on an Illumina HiSeq2000 machine was performed by the Biopolymers Facility at Harvard Medical School (<http://genome.med.harvard.edu>). We ran 100 cycle paired-end reads for each sample. Sequencing data was analyzed using Galaxy (<http://usegalaxy.org/>) ([@bib18]; [@bib20]; [@bib8]). Specifically, we used TopHat to align reads to the *Drosophila melanogaster* reference genome (BDGP R5/dm3) and CuffDiff with replicate analysis using a false discovery rate of 0.05 and no additional parameters to compare sample pairs ([@bib17]; [@bib73]). Genes were defined as synergistically up- or down- regulated by N/Src only if the adjusted p-value was less than 0.05 for all of the following pairs: N/Src vs N, N/Src vs Src, and N/Src vs WT control. Synergistic targets were further defined as rescued by Bsk^DN^ if the adjusted p-value for Bsk^DN^/N/Src vs N/Src was less than 0.05. Mapping of *Drosophila* genes to human orthologs was performed as for screen hits above.
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10.7554/eLife.05996.017

###### 

List of Exelixis mutant lines that enhance or suppress the *E1Gal4; UAS-N*^*act*^ -induced large eye phenotype. Lines in bold appear more than once in this table as they may affect more than one target gene. 26 of these lines were retested using qPCR for *puc* and *MMP1* in *vgGal4;UAS-N*^*act*^ wing discs. These genes were determined to be upregulated if the fold change by qPCR vs isogenic wild-type controls was at least 1.5. *MMP1* upregulation was further verified by immunostaining.

**DOI:** [http://dx.doi.org/10.7554/eLife.05996.017](10.7554/eLife.05996.017)

10.7554/eLife.05996.018

###### 

GO term enrichment analysis for Notch interactors. Enrichment analysis was performed with DAVID ([http://david.abcc.ncifcrf.gov](http://david.abcc.ncifcrf.gov/)), using the total Exelixis gene list as background; corrected p-values are shown using both the Benjamini--Hochberg and Bonferroni corrections.

**DOI:** [http://dx.doi.org/10.7554/eLife.05996.018](10.7554/eLife.05996.018)

10.7554/eLife.05996.019

###### 

List of genes synergistically regulated by N^act^ and Src42A^CA^ as determined by RNA-seq analysis (P-adj \< 0.05 for NS vs N, S, and WT). Genotypes: NS: *vgGal4/UAS-N*^*act*^*; UAS-Src42A*^*CA*^*/+*, S: *vgGal4/+; UAS-Src42A*^*CA*^*/+*, N: *vgGal4/UASN*^*act*^*, WT: vgGal4/+*, BNS: *UAS-Bsk*^*DN*^*/+, vgGal4/UAS-N*^*act*^*, UAS-Src42A*^*CA*^*/+*.

**DOI:** [http://dx.doi.org/10.7554/eLife.05996.019](10.7554/eLife.05996.019)

10.7554/eLife.05996.020

###### 

RNA-seq data for known N/Src targets. Genotypes: NS: *vgGal4/UAS-N*^*act*^*; UAS-Src42A*^*CA*^*/+*, S: *vgGal4/+; UAS-Src42A*^*CA*^*/+*, N: *vgGal4/UASN*^*act*^*, WT: vgGal4/+*, BNS: *UAS-Bsk*^*DN*^*/+, vgGal4/UAS-N*^*act*^*, UAS-Src42A*^*CA*^*/+*.

**DOI:** [http://dx.doi.org/10.7554/eLife.05996.020](10.7554/eLife.05996.020)

10.7554/eLife.05996.021

Decision letter

VijayRaghavan

K

Reviewing editor

National Centre for Biological Sciences, Tata Institute for Fundamental Research

,

India

eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "The Notch-mediated hyperplasia circuitry in *Drosophila* reveals a Src-JNK signaling axis" for consideration at *eLife*. Your article has been favorably evaluated by K VijayRaghavan (Senior editor and Reviewing editor) and two reviewers.

The Reviewing editor and the reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

It has become increasing obvious that the driving force for many cancers involves combinations of signalling pathways. Identifying fundamental synergies between pathways is therefore of major significance. In this manuscript, the authors investigate the consequences from combined activity of Notch and Src. The manuscript reports the results of a genome-wide genetic screen to identify modifiers of Notch-mediated hyperplasia in *Drosophila*. From the list of modifiers, the authors focus their attention on Src and in the involvement of JNK on the N/Src synergy. A valuable contribution is the screen itself whose results will be welcomed by the research community. Therefore, giving more prominence to the screen and its results, compared to the Src/N synergy (which is important too, see below) could make the paper\'s general value more apparent.

The experiments reveal that the phenotypes from combining ectopic Notch (expressing N^act^) and from ectopic Src (expressing various forms) are considerably more severe than either alone. Notably the tissues exhibit exacerbated hyperplasia. Additional experiments demonstrate that there are changes in cell cycle regulation, enhanced apoptosis and altered expression of a number of different types of downstream genes including *MMP1*, *decapo*, JAK-STAT ligands (*upds*). The authors also perform RNA-seq to characterize fully the transcriptome of the different genotypes. These are therefore substantial and valuable studies that are analysed but also provide data to the community for further mechanistic studies.

There are some intriguing aspects of the data from the screen that the authors could elaborate as discussed below.

An interesting feature of the manuscript is the demonstration that synergy between Notch and Src42A in the eye and wing discs causes hyperplasia and activates JNK, and that halved Notch activity can rescue the phenotype of over-expressed Src: the striking result is the rescue of Src64B phenotype in N/+ heterozygotes. These data suggest that Src64B requires Notch for many actions, potentially a profound observation. One concern about this, and some other experiments, is that they rely on *vg-Gal4* driver. As *vg* is regulated by Notch activity, there is a possibility that the suppression in N/+ and the augmented phenotypes with N^act^ are due to changes in Gal4 expression, leading to less or more Src being expressed respectively. At least some of the experiments should be repeated with a Notch-independent driver (e.g. engrailed-Gal4) to rule out this possibility. Or alternative ways of addressing this concern need to be elaborated. This important issue bears reiterating: Given the likelihood that *vg-GAL4* is influenced by Notch activity, at least some of the core findings, including this one, should be reproduced with another strategy.

Several of the results from the screen are intriguing and merit discussion. For example, the authors could elaborate on their finding of *nanos (d06728)* as a suppressor of somatic hyperplasia. A second interesting aspect of the results of the screening is the involvement of *CycB3 (d04775)*. It is remarkable that loss of function of a mitotic cyclin can enhance Notch-mediated hyperplasia and it is striking that none of the other cyclins appears as a modifier. Something similar applies to *Bub1 (c04512)*, which shows up as a strong enhancer while none of the other gatekeepers of the metaphase to anaphase transition (*Mad3/BubR1, Mad2,* or *Bub3*) do so.

Previous studies investigating Src64 reported some similar phenotypes (MMP1, apoptosis, JNK activity; Cell Death Dis.;4:e864; Oncogene.33(16):2027-39). It would be helpful to place the current results in the context of the previous studies of ectopic Src, which also clearly demonstrated that JNK was required. It is therefore not unexpected that bsk^DN^ blocks many of these phenotypes (as shown previously). What is unclear is how N^act^ augments these Src phenotypes. This remains a major gap in the current work that should be discussed in a revised version.

The RNA-seq experiment does not appear to support other qPCR/ immunofluorescence data in the manuscript: *MMP1*, *puc*, *dap*, *upd* are not included in the genes synergistically regulated. Do the authors have an explanation? As it stands these data undermine their conclusions. Use of additional methods to substantiate core targets (*dap*, *upd*, *E(spl)mγ*) would strengthen their conclusions (e.g. in situ hybridisation or reporter genes ) and would give useful insight into whether the effects are autonomous.

The data showing effects on the Zone of non-proliferating cells (ZNC) in [Figure 4B](#fig4){ref-type="fig"} are not sufficiently clear. The disc appears to totally lack a ZNC. Is this because of a broad non-autonomous effect or is the disc younger?

Additional controls would strengthen the conclusions. Most studies of this type control for the numbers of UAS present (using *UAS-GFP* or *UAS-lacZ* etc.) and also mark the region of ectopic expression (e.g. Oncogene. 33(16):2027-39). Although it is unlikely that UAS titration has confounded the results here (in most experiments there is an increased phenotype) there are some genotypes where this could be a factor. In addition, for [Figure 7](#fig7){ref-type="fig"}, controls without the balancer chromosomes are needed.

Mateos et al. (Oncogene, 2007; [doi:10.1038/sj.onc.1210124](http://dx.doi.org/10.1038/sj.onc.1210124)) have previously shown in avian neural cells that intracellular Notch suppresses v-Src-induced transformation and documented that such a suppression correlates with changes in JNK-dependent signalling. Mateos et al. should be cited and discussed. A previous manuscript from the same group on the Notch/Mef2 synergy (Pallavi1, et al. 2012, EMBO J) partially overlaps with the submitted manuscript. This matter should be addressed in revision.

10.7554/eLife.05996.022

Author response

*It has become increasing obvious that the driving force for many cancers involves combinations of signalling pathways. Identifying fundamental synergies between pathways is therefore of major significance. In this manuscript, the authors investigate the consequences from combined activity of Notch and Src. The manuscript reports the results of a genome-wide genetic screen to identify modifiers of Notch-mediated hyperplasia in* Drosophila*. From the list of modifiers, the authors focus their attention on Src and in the involvement of JNK on the N/Src synergy. A valuable contribution is the screen itself whose results will be welcomed by the research community. Therefore, giving more prominence to the screen and its results, compared to the Src/N synergy (which is important too, see below) could make the paper\'s general value more apparent*.

We fully agree with you that the results of the screen will be valuable to the community and welcome your comment. As such, we have added a deeper discussion of these results (both in the Results and Discussion sections). We have added a panel to [figure 1](#fig1){ref-type="fig"} ([Figure 1C](#fig1){ref-type="fig"}) that shows preexisting known and predicted interactions between all cell cycle genes from the screen; this reveals that we have identified novel links between these genes and Notch. We've also added significantly to the Discussion regarding the nature of the collection and our evaluation of the strengths/weaknesses thereof. Specifically, we think it's crucial to convey the fact that the screen was not saturating; therefore we do not expect to recover all of the possible modifiers of Notch. Finally, we've discussed some interesting specific genes/pathways from the screen, including the *nanos/cyclinB3* connection mentioned below.

*The experiments reveal that the phenotypes from combining ectopic Notch (expressing N*^*act*^*) and from ectopic Src (expressing various forms) are considerably more severe than either alone. Notably the tissues exhibit exacerbated hyperplasia. Additional experiments demonstrate that there are changes in cell cycle regulation, enhanced apoptosis and altered expression of a number of different types of downstream genes including* MMP1*,* decapo*, JAK-STAT ligands (*upds*). The authors also perform RNA-seq to characterize fully the transcriptome of the different genotypes. These are therefore substantial and valuable studies that are analysed but also provide data to the community for further mechanistic studies*[.]{.ul}

*There are some intriguing aspects of the data from the screen that the authors could elaborate as discussed below*.

*An interesting feature of the manuscript is the demonstration that synergy between Notch and Src42A in the eye and wing discs causes hyperplasia and activates JNK, and that halved Notch activity can rescue the phenotype of over-expressed Src: the striking result is the rescue of Src64B phenotype in N/+ heterozygotes. These data suggest that Src64B requires Notch for many actions, potentially a profound observation. One concern about this, and some other experiments, is that they rely on* vg-Gal4 *driver. As* vg *is regulated by Notch activity, there is a possibility that the suppression in N/+ and the augmented phenotypes with N*^*act*^ *are due to changes in Gal4 expression, leading to less or more Src being expressed respectively. At least some of the experiments should be repeated with a Notch-independent driver (e.g. engrailed-Gal4) to rule out this possibility. Or alternative ways of addressing this concern need to be elaborated. This important issue bears reiterating: Given the likelihood that* vg-GAL4 *is influenced by Notch activity, at least some of the core findings, including this one, should be reproduced with another strategy*.

For the overexpression experiments, we have used *dppGal4*, which is independent of Notch, to validate our *vgGal4* results. We find that *dppGal4*-driven N^act^/Src also causes upregulation of MMP1 ([Figure 4](#fig4){ref-type="fig"}), increased apoptosis ([Figure 4](#fig4){ref-type="fig"}), and cell cycle perturbation ([Figure 5](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

Regarding the rescue experiment with *N*^*55e11*^*/+* and *UAS-N*^*RNAi*^, we have attempted to perform this experiment in a vg-independent manner using several approaches but this has failed. Specifically, we have tried to use both *dppGal4* and *C96Gal4* wing drivers, as well as both the *Csk*^*j1d8/j1d8*^ mutant (which inactivates Csk, an inhibitor of Src) and the *Csk*^*j1d8*^*/+,puc*^*E69*^*/+* trans-heterozygous mutant, which were both reported by Langton et al. (Dev Cell, 2007) to cause Src-like phenotypes in the wing disc. Unfortunately, all of the above approaches failed due to excessive lethality and we were thus unable to replicate the rescue experiment using a vg-independent method. We have therefore decided to move this result into the supplemental data (it is now [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}) and explicitly state in the text the caveat that effects of Notch reduction on *vgGal4* may play a role. We also avoid drawing any conclusions in the Discussion based on this finding.

*Several of the results from the screen are intriguing and merit discussion. For example, the authors could elaborate on their finding of* nanos *(*d06728*) as a suppressor of somatic hyperplasia. A second interesting aspect of the results of the screening is the involvement of* CycB3 (d04775)*. It is remarkable that loss of function of a mitotic cyclin can enhance Notch-mediated hyperplasia and it is striking that none of the other cyclins appears as a modifier. Something similar applies to* Bub1 (c04512)*, which shows up as a strong enhancer while none of the other gatekeepers of the metaphase to anaphase transition (*Mad3/BubR1, Mad2, *or* Bub3*) do so*.

As mentioned above, we have added substantial discussion of the results from the genetic screen, including mention of *cyclin B3* and *nanos*. With regard to only single members of a pathway or process showing up in the screen, it is important not to read too much into such things as they may be caused by the fact that the screen is not saturating (this and other limitations of the screen are now discussed). However, we note that *BubR1, Mad2*, and *Bub3* are indeed represented in the Exelixis collection and were not identified as modifiers in our screen; we now discuss this as a potentially interesting avenue for further study.

*Previous studies investigating Src64 reported some similar phenotypes (MMP1, apoptosis, JNK activity; Cell Death Dis.;4:e864; Oncogene.33(16):2027-39). It would be helpful to place the current results in the context of the previous studies of ectopic Src, which also clearly demonstrated that JNK was required. It is therefore not unexpected that bsk*^*DN*^ *blocks many of these phenotypes (as shown previously). What is unclear is how N*^*act*^ *augments these Src phenotypes. This remains a major gap in the current work that should be discussed in a revised version*.

This was indeed an omission. We've now included these studies in our Discussion. While they do indeed show that Src activates JNK/MMP1/apoptosis to promote invasive behavior, they do not document hyperplastic growth. We believe that the addition of Notch is important to contribute the equally important overgrowth aspect of oncogenesis. It is striking that even in the presence of such massive apoptosis as induced by JNK, N/Src tissues can still overgrow.

*The RNA-seq experiment does not appear to support other qPCR/ immunofluorescence data in the manuscript:* MMP1*,* puc*,* dap*,* upd *are not included in the genes synergistically regulated. Do the authors have an explanation? As it stands these data undermine their conclusions*.

We have included a new table ([Supplementary file 4](#SD4-data){ref-type="supplementary-material"}) containing the RNA-seq data for these genes. For *MMP1* and the *upd* genes, the discrepancy can be largely explained by the observation that Src alone can induce these genes to a lesser degree. This seems to sometimes be enough for the algorithm/false positive correction to deem the N/Src vs. Src condition statistically insignificant. For *dap*, we see a significant reduction of the Notch-induced *dap* in the presence of Src; however, we do not see the reduction below WT that we see with qPCR. This discrepancy remains unexplained at the moment; we make note of this fact in the text. With regards to *puc*, we believe that the RNA-seq gave a false positive reading for the WT condition that threw off the subsequent calculations. This is explicitly now mentioned in the text.

*Use of additional methods to substantiate core targets (*dap, upd, E(spl)mγ*) would strengthen their conclusions (e.g. in situ hybridisation or reporter genes ) and would give useful insight into whether the effects are autonomous*.

We have performed experiments using the *LacZ* reporter lines for *upd*, *dap*, and *E(spl)mγ* as you suggested. The new results are shown in [Figures 5, 6](#fig5 fig6){ref-type="fig"}, and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"} respectively and support our conclusions.

*The data showing effects on the Zone of non-proliferating cells (ZNC) in* [*Figure 4B*](#fig4){ref-type="fig"} *are not sufficiently clear. The disc appears to totally lack a ZNC. Is this because of a broad non-autonomous effect or is the disc younger*?

We've replaced these images with confocal images that are clearer and better stage-matched. You are correct in that there is some non-autonomous effect on proliferation induced by both N alone and N/Src that causes distortion (specifically, expansion of the dorsal part of the wing pouch), and we've now pointed this out in the text as well.

*Additional controls would strengthen the conclusions. Most studies of this type control for the numbers of UAS present (using* UAS-GFP *or* UAS-lacZ *etc.) and also mark the region of ectopic expression (e.g. Oncogene. 33(16):2027-39). Although it is unlikely that UAS titration has confounded the results here (in most experiments there is an increased phenotype) there are some genotypes where this could be a factor*.

We have performed a control experiment where we have compared discs containing one copy each of *UAS-GFP, UAS-N*^*act*^, *and UAS-Src42A*^*CA*^ (3 UAS transgenes total) to discs containing only *UAS-N*^*act*^ and *UAS-Src42A*^*CA*^ (2 UAS transgenes total). We find that there is no difference in phenotype between the two, indicating that the rescue we see when we add *UAS-Bsk*^*DN*^ to *UAS-N*^*act*^ and *UAS-Src42A*^*CA*^ is not a result of Gal4/UAS titration. This result is shown in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}.

With regards to marking the region of ectopic expression, in the experiments using the *dppGal4* driver ([Figure 4](#fig4){ref-type="fig"}, as well as the existing ZNC experiment in [Figure 5](#fig5){ref-type="fig"}), we have included *UAS-GFP* to mark the expression domain.

*In addition, for* [*Figure 7*](#fig7){ref-type="fig"}*, controls without the balancer chromosomes are needed*.

For this experiment (now [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}), a control without the balancer chromosome has been added in panel D.

*Mateos et al. (Oncogene, 2007;* [*doi:10.1038/sj.onc.1210124*](http://dx.doi.org/10.1038/sj.onc.1210124)*) have previously shown in avian neural cells that intracellular Notch suppresses v-Src-induced transformation and documented that such a suppression correlates with changes in JNK-dependent signalling. Mateos et al. should be cited and discussed*.

Indeed! We have cited and discussed this report as you suggested. We note that Notch can act as both an oncogene and a tumor suppressor depending on context, and this may explain the discrepancy between this study and the present one.

*A previous manuscript from the same group on the Notch/Mef2 synergy (Pallavi1, et al. 2012, EMBO J) partially overlaps with the submitted manuscript. This matter should be addressed in revision*.

Our previous paper has been provided to *eLife* as a related manuscript. The overlapping data (showing N/Mef2 activity on MMP1, apoptosis, and JNK) is clearly described in the text as replicating our previous work; we believe that it is important to show it in the current work for comparison/control purposes.
